XML 46 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Reporting (Tables)
9 Months Ended
May. 31, 2015
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table reflects results of operations of the Company’s reportable segments (in millions):

  
Retail Pharmacy
       
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
 and
Unallocated
Items
  
Consolidated
 
Three Months Ended May 31, 2015
          
Sales to external customers
 
$
20,425
  
$
3,231
  
$
5,139
  
$
-
  
$
28,795
 
Intersegment sales
  
-
   
37
   
569
   
(606
)
  
-
 
Total Sales
  
20,425
   
3,268
   
5,708
   
(606
)
  
28,795
 
Cost of sales
  
14,898
   
1,875
   
5,148
   
(607
)
  
21,314
 
Gross Profit
  
5,527
   
1,393
   
560
   
1
   
7,481
 
Selling, general and administrative expenses
  
4,494
   
1,188
   
398
   
-
   
6,080
 
Operating Income
 
$
1,033
  
$
205
  
$
162
  
$
1
  
$
1,401
 
                     
Three Months Ended May 31, 2014
                    
Sales to external customers
 
$
19,401
  
$
-
  
$
-
  
$
-
  
$
19,401
 
Intersegment sales
  
-
   
-
   
-
   
-
   
-
 
Total Sales
  
19,401
   
-
   
-
   
-
   
19,401
 
Cost of sales
  
13,961
   
-
   
-
   
-
   
13,961
 
Gross Profit
  
5,440
   
-
   
-
   
-
   
5,440
 
Selling, general and administrative expenses
  
4,551
   
-
   
-
   
-
   
4,551
 
Equity earnings in Alliance Boots
  
135
   
-
   
-
   
-
   
135
 
Operating Income
 
$
1,024
  
$
-
  
$
-
  
$
-
  
$
1,024
 

  
Retail Pharmacy
       
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
and
Unallocated
 Items
  
Consolidated
 
Nine Months Ended May 31, 2015
          
Sales to external customers
 
$
61,027
  
$
5,248
  
$
8,647
  
$
-
  
$
74,922
 
Intersegment sales
  
-
   
67
   
926
   
(993
)
  
-
 
Total Sales
  
61,027
   
5,315
   
9,573
   
(993
)
  
74,922
 
Cost of sales
  
44,458
   
3,169
   
8,626
   
(990
)
  
55,263
 
Gross Profit
  
16,569
   
2,146
   
947
   
(3
)
  
19,659
 
Selling, general and administrative expenses
  
13,505
   
1,933
   
704
   
-
   
16,142
 
Equity earnings in Alliance Boots
  
315
   
-
   
-
   
-
   
315
 
Operating Income
 
$
3,379
  
$
213
  
$
243
  
$
(3
)
 
$
3,832
 
                     
Nine Months Ended May 31, 2014
                    
Sales to external customers
 
$
57,335
  
$
-
  
$
-
  
$
-
  
$
57,335
 
Intersegment sales
  
-
   
-
   
-
   
-
   
-
 
Total Sales
  
57,335
   
-
   
-
   
-
   
57,335
 
Cost of sales
  
41,093
   
-
   
-
   
-
   
41,093
 
Gross Profit
  
16,242
   
-
   
-
   
-
   
16,242
 
Selling, general and administrative expenses
  
13,499
   
-
   
-
   
-
   
13,499
 
Equity earnings in Alliance Boots
  
465
   
-
   
-
   
-
   
465
 
Operating Income
 
$
3,208
  
$
-
  
$
-
  
$
-
  
$
3,208
 
                     
Total assets:
                    
May 31, 2015
 
$
41,714
  
$
22,514
  
$
13,043
  
$
(6,627
)
 
$
70,644
 
August 31, 2014
  
44,255
   
-
   
-
   
(7,005
)
  
37,250
 
Schedule of Earnings Before Interest and Income Tax Provision
The following table reconciles the operating income from each reportable segment to earnings before interest and income tax provision (in millions):

  
For the Three Months Ended
  
For the Nine Months Ended
 
  
May 31,
2015
  
May 31,
2014
  
May 31,
2015
  
May 31,
2014
 
Operating income:
        
Retail Pharmacy USA
 
$
1,033
  
$
1,024
  
$
3,379
  
$
3,208
 
Retail Pharmacy International
  
205
   
-
   
213
   
-
 
Pharmaceutical Wholesale
  
162
   
-
   
243
   
-
 
Eliminations/Other
  
1
   
-
   
(3
)
  
-
 
Gain on previously held equity interest
  
-
   
-
   
706
   
-
 
Other income
  
461
   
124
   
1,164
   
290
 
Earnings Before Interest and Income Tax provision (EBIT)
 
$
1,862
  
$
1,148
  
$
5,702
  
$
3,498